ACHAOGEN INC's ticker is AKAOQ and the CUSIP is 004449104. A total of 106 filers reported holding ACHAOGEN INC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $121,000 | -72.0% | 264,900 | -24.6% | 0.00% | – |
| Q4 2018 | $432,000 | -47.6% | 351,357 | +70.1% | 0.00% | -100.0% |
| Q3 2018 | $824,000 | -85.0% | 206,500 | -51.3% | 0.00% | -66.7% |
| Q2 2018 | $5,488,000 | 0.0% | 423,800 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $5,488,000 | -20.5% | 423,800 | -34.1% | 0.01% | -25.0% |
| Q4 2017 | $6,903,000 | +2201.0% | 642,700 | +3318.6% | 0.01% | – |
| Q3 2017 | $300,000 | -93.9% | 18,800 | -95.0% | 0.00% | -100.0% |
| Q4 2016 | $4,911,000 | +247.1% | 377,200 | +27.6% | 0.01% | +166.7% |
| Q3 2016 | $1,415,000 | +119.4% | 295,500 | +73.7% | 0.00% | +200.0% |
| Q2 2016 | $645,000 | +262.4% | 170,100 | +164.1% | 0.00% | – |
| Q1 2016 | $178,000 | +31.9% | 64,400 | +174.0% | 0.00% | – |
| Q4 2015 | $135,000 | +125.0% | 23,500 | +126.0% | 0.00% | – |
| Q3 2015 | $60,000 | -86.8% | 10,400 | -86.2% | 0.00% | -100.0% |
| Q2 2015 | $455,000 | +97.0% | 75,529 | +218.7% | 0.00% | – |
| Q1 2015 | $231,000 | – | 23,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,281,152 | $13,759,572,000 | 14.48% |
| Foresite Capital Management III, LLC | 2,375,000 | $25,508,000 | 7.16% |
| Prosight Management, LP | 570,920 | $6,132,000 | 4.51% |
| NEA Management Company, LLC | 5,215,128 | $56,010,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 204,538 | $2,197,000 | 0.78% |
| Marcus Capital, LLC | 17,400 | $187,000 | 0.72% |
| Iguana Healthcare Management, LLC | 75,000 | $806,000 | 0.52% |
| FIRST MIDWEST BANK TRUST DIVISION | 374,007 | $4,017,000 | 0.50% |
| DSC Advisors, L.P. | 70,000 | $752,000 | 0.44% |
| Polar Capital LLP | 1,881,380 | $20,206,000 | 0.21% |